INVESTORS & MEDIA HOME Latest ASX Announcements 10 July 2026 Ryoncil Q4 Net Revenue of US$36M and US$115M for Full Year 01 July 2026 Receives FDA BLA Filing Number and Requests Modular Review 30 June 2026 Becoming a substantial holder 29 June 2026 Ceasing to be a substantial holder More Upcoming Events There are currently no events scheduled. More Stock Quote Exchange : Price : Change : Volume : Data as of 09 July 2026 8:39 PM EDT Exchange : Price : Change : Volume : Data as of 09 July 2026 8:39 PM EDT Minimum 15 minutes delayed. Source: LSEG Mesoblast R&D Day Mesoblast R&D Day Financial Results and Operational Update for the Period Ended December 31, 2025 Financial Results and Operational Update for the Period Ended December 31, 2025 E-mail Alerts Sign up here to receive e-mail alerts.
